Global Prescription Delivery Service Industry is expected to reach US$ 287.9 Million by 2034, With a 5.7% CAGR | FMI Study

Posted on 2024-04-01 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

Global Prescription Delivery Services Industry

The Global Prescription Delivery Service Industry is experiencing a surge in popularity, fueled by consumer demand for convenience. A recent market analysis projects the market to reach US$ 287.9 million by 2034, reflecting a steady climb from its current valuation of US$ 165.4 million in 2024. This translates to a compound annual growth rate (CAGR) of 5.7%.

Amid modern advancements in prescription delivery systems, the industry has ushered in a new era of healthcare. This evolution brings forth a range of benefits, including 24/7 customer support, precise dosage control, improved medication adherence, and valuable feedback for healthcare professionals.

A pivotal component of an efficient healthcare infrastructure is a timely drug supply. With the manufacturing of prescription pharmaceuticals on the rise, driven by the escalating incidence of chronic and infectious diseases, manufacturers are compelled to develop efficient distribution systems.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12534

The landscape of prescription delivery services has been significantly changed by improvements in customer touch points and supply chains, including e-commerce, convenience stores, and retail outlets. Smooth client experiences are being ushered in by innovations like drone-based deliveries and tracker-based medicines.

Global Prescription Delivery Service Industry – Key Takeaways:

Market Poised for Growth: The prescription delivery service market is anticipated to grow significantly, reaching nearly US$ 288 million by 2034.
Convenience Reigns Supreme: Consumer demand for time-saving solutions is a key driver of market growth.
Shifting Healthcare Landscape: The rise of e-commerce in healthcare and an aging population contribute to the market’s expansion.

“Adoption of self-checkout kiosks and medicine dispensing machines shall enhance the medicine purchasing experience of customers, permitting vendors to experience greater customer loyalty,” Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Growth is especially anticipated to be robust across the U.S., China, and India, countries with the highest rates of infections. Collectively accounting for 40% of the global infection rate, these countries have witnessed an unprecedented increase in hoarding prescription medicines by individual households. This shall continue until the latter half of 2021.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-12534

Market Witnessing Entry of e-Commerce Players

The Prescription Delivery Service Market is witnessing the entry of e-commerce, pharmacy, and retail chains, albeit at a local or regional level. Technological developments, new product launches, and collaborations characterize some critical expansion strategies of market players.

Some of the key players in the Prescription Delivery Service Market are Walgreens Co., Walmart Stores Inc., CVS Health, Giant Eagle Inc., Express Scripts Holding Company, Ali Health and Kroger Co. to name a few.

Besides these established players, several startup companies are also emerging as potential game changers in the industry. These include NetMeds, Kfyao, Capsule, Myra Medicines, NURX, MedAvail, Zipdrug, Insightful, and ScriptDrop to name a few.

Walgreens, a prominent retail pharmaceutical distributor, has a robust presence in the Global Prescription Delivery Services Industry. The company offers refills, auto refills, drug information, and home delivery services.

In 2017, the company acquired Rite Aid for a sum of US$ 5.2 billion, resulting in the merger of two of the United States’ three largest pharmacy chains.

Key Market Segments Covered In Global Prescription Delivery Service Industry Research

By Disease Indication:

Prescription Drugs
- Diabetes
- Hypertension
- Cholesterols disorders
Wellness Supplement
Diagnostics Kits
OTC Drugs

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-12534

By Distribution Channel:

Pharmacy Stores
- Retail Pharmacy
- Drug Stores
Healthcare Institutions
Clinics
Research institutes

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick